Background illustration for clinical trials search

Paid Clinical Trials Salem

Discover 955 paid clinical trials in Salem, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Portland OR, San Diego CA, Phoenix AZ, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Observational Study of Corneal Opacities in Adults

for
Corneal Opacities (Scar and Stromal Dystrophy)
Location: Portland OR
Sponsor: Oregon Health and Science University

Sex: All

Age: 18 - 70+

Code: NCT02109471

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Portland OR, Puyallup WA, Tacoma WA, Redmond WA,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase 3, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Portland OR, Eugene OR, Seattle WA, Lewiston ID,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase 2, Recruiting

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for
Growth Hormone Deficiency
Location: Portland OR, Seattle WA, Boise ID, Sacramento CA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Pulmonary Hypertension Association Registry

for
Pulmonary Arterial Hypertension,
Location: Portland OR, Seattle WA, Sacramento CA,
Sponsor: Pulmonary Hypertension Association, Inc.

Sex: All

Age: 0+

Code: NCT04071327

Recruiting

Z1 Hip System: Post-Market Clinical Follow Up Study

for
Hip Osteoarthritis,
Location: Portland OR, Platte City MO, Cleveland OH, Charlotte NC,
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT07104279

Recruiting

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

for
Focal Onset Seizures
Location: Portland OR, Boise ID, Los Angeles CA, Orange CA,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05716100

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

for
Non-small Cell Lung Cancer (NSCLC)
Location: West Haven-Sylvan OR, Portland OR, Eugene OR,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07288177

Phase 2, Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Portland OR, Tacoma WA, Vancouver, Roseville CA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase 3, Recruiting

A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC

for
Carcinoma, Non-Small-Cell Lung
Location: Portland OR, Stanford CA, Duarte CA, Irvine CA, Toronto,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07586202

Phase 2, Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Portland OR, Seattle WA, Fullerton CA, Orange CA,
Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07104032

Phase 3, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Portland OR, Seattle WA, Vancouver, Calgary,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Portland OR, Vancouver WA, Post Falls ID,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Portland OR, Vancouver, Edmonton, Las Vegas NV,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

for
Lung Neoplasm Malignant
Location: Portland OR, Chicago IL, Clermont FL
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07286149

Phase 1, Phase 2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Portland OR, Los Angeles CA, Duarte CA, San Diego CA,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

for
Breast Cancer
Location: Portland OR, Tacoma WA, Seattle WA, Edmonds WA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT06790693

Phase 3, Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

for
Relapsed Hematologic Malignancy,
Location: Portland OR, Seattle WA, Salt Lake City UT,
Sponsor: Curis, Inc.

Sex: All

Age: 18+

Code: NCT03328078

Phase 1, Phase 2, Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Portland OR, Tacoma WA, Everett WA, Meridian ID,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting